Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Infections 1Hot Flashes 1Fever 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 10Filgrastim 8Methylprednisolone 4Etoposide 4fludarabine phosphate 3Radiotherapy 3Cyclosporine 3aldesleukin 2Vorinostat 2Tacrolimus 2Rituximab 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Mycophenolic Acid 2Immunologic Techniques 2Flow Cytometry 2Biopsy 2Antilymphocyte Serum 2venetoclax 1ontuxizumab 1obatoclax 1ispinesib 1imetelstat 1ibritumomab tiuxetan 1gallium nitrate 1exatecan 1copanlisib 1cediranib 1beta-Glucans 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Dendritic Cell Sarcoma, Interdigitating × Mannose-Binding Lectin × Clear all
NCT00886496 2012-06-20

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Enzon Pharmaceuticals, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fever, Infections, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neutropenia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Hot Flashes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡